Article
Biologic and Therapeutic Implications of Genomic Alterations in Acute Lymphoblastic Leukemia
25 Aug 2021
Abstract excerpt
Acute lymphoblastic leukemia (ALL) is the most successful paradigm of how risk-adapted therapy and detailed understanding of the genetic alterations driving leukemogenesis and therapeutic response may dramatically improve treatment outcomes, with cure rates now exceeding 90% in children. However, ALL still represents a leading cause of cancer-related death in the young, and the outcome for older adolescents and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
